These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 4851731)

  • 21. Effects of amphetamines on the metabolism of catecholamines in the rat brain.
    Baldessarini RJ; Harris JE
    J Psychiatr Res; 1974; 11():41-3. PubMed ID: 4477777
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of central catecholamine alterations by 6-hydroxydopamine on shuttle box avoidance acquistion.
    Cooper BR; Breese GR; Howard JL; Grant LD
    Physiol Behav; 1972; 9(5):727-31. PubMed ID: 4655165
    [No Abstract]   [Full Text] [Related]  

  • 23. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
    Peterson DW; Sparber SB
    J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
    [No Abstract]   [Full Text] [Related]  

  • 24. Some aspects of the mechanism of action of various stimulant amphetamine analogues.
    Scheel-Krüger J
    Psychiatr Neurol Neurochir; 1972; 75(3):179-92. PubMed ID: 4402652
    [No Abstract]   [Full Text] [Related]  

  • 25. Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine.
    Breese GR; Traylor TD
    Br J Pharmacol; 1971 May; 42(1):88-99. PubMed ID: 5580702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of dopamine neural systems to the behavioral alterations produced by 6-hydroxydopamine administration into brain.
    Cooper BR; Breese GR
    Adv Biochem Psychopharmacol; 1974; 12(0):353-68. PubMed ID: 4609223
    [No Abstract]   [Full Text] [Related]  

  • 27. Catecholamines and self-stimulation behavior: effects of brain levels after stimulation, and pretreatment with DL- -methyl-rpo-tyrosine.
    Yuwiler A; Olds ME
    Brain Res; 1973 Feb; 50(2):331-40. PubMed ID: 4705502
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative involvement of dopamine and noradrenaline in rate-free self-stimulation in substania nigra, lateral hypothalamus, and mesencephalic central gray.
    Liebman JM; Butcher LL
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 284(2):167-94. PubMed ID: 4152814
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies on myocardial histamine. Effects of catecholamine-depleting drugs.
    Harvey SC
    Arch Int Pharmacodyn Ther; 1978 Mar; 232(1):141-9. PubMed ID: 666455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of steady-state kinetics to the study of catecholamine turnover after monoamine oxidase inhibition or reserpine administration.
    Neff NH; Costa E
    J Pharmacol Exp Ther; 1968 Mar; 160(1):40-7. PubMed ID: 5639109
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of depletion of cerebral monoamines on the concentration of glycogen and on amphetamine-induced glycogenolysis in the brain.
    Hutchins DA; Rogers KJ
    Br J Pharmacol; 1973 May; 48(1):19-29. PubMed ID: 4269287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopaminergic and noradrenergic substrates of positive reinforcement: differential effects of d- and l-amphetamine.
    Phillips AG; Fibiger HC
    Science; 1973 Feb; 179(4073):575-7. PubMed ID: 4686463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between central catecholamine level and post-decapitation convulsion in rats treated with 6-hydroxydopamine.
    Suenaga N; Yamada K; Fukuda T
    Brain Res; 1977 Feb; 122(1):165-9. PubMed ID: 837220
    [No Abstract]   [Full Text] [Related]  

  • 34. The effects of reserpine and 6-hydroxydopamine on the concentrations of some arylakylamines in rat brain.
    Boulton AA; Juorio AV; Philips SR; Wu PH
    Br J Pharmacol; 1977 Jan; 59(1):209-14. PubMed ID: 837000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine.
    Creese I; Iversen SD
    Brain Res; 1973 Jun; 55(2):369-82. PubMed ID: 4145950
    [No Abstract]   [Full Text] [Related]  

  • 36. Catecholamines and self-stimulation: pharmacological differences between near- and far-lateral hypothalamic sites.
    Stephens DN; Herberg LJ
    Brain Res; 1975 Jun; 90(2):348-51. PubMed ID: 1139312
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of 6-hydroxydopamine on some actions of tremorine and oxotremorine.
    Slater P
    Eur J Pharmacol; 1974 Feb; 25(2):130-7. PubMed ID: 4435017
    [No Abstract]   [Full Text] [Related]  

  • 38. Ventricular infusion of norepinephrine and amphetamine: direct versus indirect action.
    Segal DS; McAllister C; Geyer MA
    Pharmacol Biochem Behav; 1974; 2(1):79-86. PubMed ID: 4857225
    [No Abstract]   [Full Text] [Related]  

  • 39. The possible central stimulant mechanisms of some appetite suppressants.
    Offermeier J; Potgieter B
    S Afr Med J; 1972 Jan; 46(4):72-7. PubMed ID: 5058666
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of central effects of 6-aminodopamine and 6-hydroxydopamine on catecholamine levels.
    Oke A; Freeman R; Adams RN
    Eur J Pharmacol; 1974 Apr; 26(1):125-7. PubMed ID: 4831981
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.